Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway
•Diabetes- induced cognitive deficit could be ameliorated by zeaxanthin.•Zeaxanthin could protect hippocampal neurons against hyperglycemia.•Zeaxanthin improved cognitive deficit through activating PI3K/AKT signaling pathway. Published studies have shown that cognitive deficit is a characteristic ma...
Saved in:
Published in | Brain research bulletin Vol. 132; pp. 190 - 198 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Diabetes- induced cognitive deficit could be ameliorated by zeaxanthin.•Zeaxanthin could protect hippocampal neurons against hyperglycemia.•Zeaxanthin improved cognitive deficit through activating PI3K/AKT signaling pathway.
Published studies have shown that cognitive deficit is a characteristic manifestation of neurodegenerative disease in diabetes. However, there is no effective prevention and treatment for this diabetes-associated behavior disorder. In the present study, we attempted to elucidate the effect of zeaxanthin on cognitive deficit and the change in the hippocampus correlated with cognitive decline in diabetic rats. Diabetic rats in this study were induced by high-fat diet and low-dose streptozocin (STZ), cognitive ability of rats were evaluated use morris water maze (MWM) and morphology change in hippocampus was assessed by cresyl violet stain. Moreover, we detected the expression of phosphorylated serine/threonine kinase (p-AKT) and Cleaved caspase-3, and the activity of nuclear factor-κB (NF-κB) use western-blot (WB).
Results displayed that supplementation with zeaxanthin reduce blood glucose, improve cognitive deficit, survive neural cell, increase p-AKT level, inhibit Cleaved caspase-3 level and NF-κB nuclear transcription in hippocampus. This study demonstrated that zeaxanthin ameliorate diabetes-related cognitive deficit may by means of protecting neural cell from hyperglycemia involved in AKT/NF-κB signaling pathway. This study may provide a potential therapeutic approach for the prevention of diabetes- associated cognitive deficit. |
---|---|
AbstractList | •Diabetes- induced cognitive deficit could be ameliorated by zeaxanthin.•Zeaxanthin could protect hippocampal neurons against hyperglycemia.•Zeaxanthin improved cognitive deficit through activating PI3K/AKT signaling pathway.
Published studies have shown that cognitive deficit is a characteristic manifestation of neurodegenerative disease in diabetes. However, there is no effective prevention and treatment for this diabetes-associated behavior disorder. In the present study, we attempted to elucidate the effect of zeaxanthin on cognitive deficit and the change in the hippocampus correlated with cognitive decline in diabetic rats. Diabetic rats in this study were induced by high-fat diet and low-dose streptozocin (STZ), cognitive ability of rats were evaluated use morris water maze (MWM) and morphology change in hippocampus was assessed by cresyl violet stain. Moreover, we detected the expression of phosphorylated serine/threonine kinase (p-AKT) and Cleaved caspase-3, and the activity of nuclear factor-κB (NF-κB) use western-blot (WB).
Results displayed that supplementation with zeaxanthin reduce blood glucose, improve cognitive deficit, survive neural cell, increase p-AKT level, inhibit Cleaved caspase-3 level and NF-κB nuclear transcription in hippocampus. This study demonstrated that zeaxanthin ameliorate diabetes-related cognitive deficit may by means of protecting neural cell from hyperglycemia involved in AKT/NF-κB signaling pathway. This study may provide a potential therapeutic approach for the prevention of diabetes- associated cognitive deficit. Highlights • Diabetes- induced cognitive deficit could be ameliorated by zeaxanthin. • Zeaxanthin could protect hippocampal neurons against hyperglycemia. • Zeaxanthin improved cognitive deficit through activating PI3K/AKT signaling pathway. Published studies have shown that cognitive deficit is a characteristic manifestation of neurodegenerative disease in diabetes. However, there is no effective prevention and treatment for this diabetes-associated behavior disorder. In the present study, we attempted to elucidate the effect of zeaxanthin on cognitive deficit and the change in the hippocampus correlated with cognitive decline in diabetic rats. Diabetic rats in this study were induced by high-fat diet and low-dose streptozocin (STZ), cognitive ability of rats were evaluated use morris water maze (MWM) and morphology change in hippocampus was assessed by cresyl violet stain. Moreover, we detected the expression of phosphorylated serine/threonine kinase (p-AKT) and Cleaved caspase-3, and the activity of nuclear factor-κB (NF-κB) use western-blot (WB). Results displayed that supplementation with zeaxanthin reduce blood glucose, improve cognitive deficit, survive neural cell, increase p-AKT level, inhibit Cleaved caspase-3 level and NF-κB nuclear transcription in hippocampus. This study demonstrated that zeaxanthin ameliorate diabetes-related cognitive deficit may by means of protecting neural cell from hyperglycemia involved in AKT/NF-κB signaling pathway. This study may provide a potential therapeutic approach for the prevention of diabetes- associated cognitive deficit.Published studies have shown that cognitive deficit is a characteristic manifestation of neurodegenerative disease in diabetes. However, there is no effective prevention and treatment for this diabetes-associated behavior disorder. In the present study, we attempted to elucidate the effect of zeaxanthin on cognitive deficit and the change in the hippocampus correlated with cognitive decline in diabetic rats. Diabetic rats in this study were induced by high-fat diet and low-dose streptozocin (STZ), cognitive ability of rats were evaluated use morris water maze (MWM) and morphology change in hippocampus was assessed by cresyl violet stain. Moreover, we detected the expression of phosphorylated serine/threonine kinase (p-AKT) and Cleaved caspase-3, and the activity of nuclear factor-κB (NF-κB) use western-blot (WB). Results displayed that supplementation with zeaxanthin reduce blood glucose, improve cognitive deficit, survive neural cell, increase p-AKT level, inhibit Cleaved caspase-3 level and NF-κB nuclear transcription in hippocampus. This study demonstrated that zeaxanthin ameliorate diabetes-related cognitive deficit may by means of protecting neural cell from hyperglycemia involved in AKT/NF-κB signaling pathway. This study may provide a potential therapeutic approach for the prevention of diabetes- associated cognitive deficit. Published studies have shown that cognitive deficit is a characteristic manifestation of neurodegenerative disease in diabetes. However, there is no effective prevention and treatment for this diabetes-associated behavior disorder. In the present study, we attempted to elucidate the effect of zeaxanthin on cognitive deficit and the change in the hippocampus correlated with cognitive decline in diabetic rats. Diabetic rats in this study were induced by high-fat diet and low-dose streptozocin (STZ), cognitive ability of rats were evaluated use morris water maze (MWM) and morphology change in hippocampus was assessed by cresyl violet stain. Moreover, we detected the expression of phosphorylated serine/threonine kinase (p-AKT) and Cleaved caspase-3, and the activity of nuclear factor-κB (NF-κB) use western-blot (WB). Results displayed that supplementation with zeaxanthin reduce blood glucose, improve cognitive deficit, survive neural cell, increase p-AKT level, inhibit Cleaved caspase-3 level and NF-κB nuclear transcription in hippocampus. This study demonstrated that zeaxanthin ameliorate diabetes-related cognitive deficit may by means of protecting neural cell from hyperglycemia involved in AKT/NF-κB signaling pathway. This study may provide a potential therapeutic approach for the prevention of diabetes- associated cognitive deficit. |
Author | Mao, Yizhen Zhou, Xiaoyan Wang, Shanshan Ying, Changjiang Chen, Lei Li, Wei Ding, Xin Qin, Li |
Author_xml | – sequence: 1 givenname: Xiaoyan surname: Zhou fullname: Zhou, Xiaoyan organization: Laboratory of Morphology, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, PR China – sequence: 2 givenname: Shanshan surname: Wang fullname: Wang, Shanshan organization: The Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, PR China – sequence: 3 givenname: Xin surname: Ding fullname: Ding, Xin organization: The Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, PR China – sequence: 4 givenname: Li surname: Qin fullname: Qin, Li organization: The Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, PR China – sequence: 5 givenname: Yizhen surname: Mao fullname: Mao, Yizhen organization: The Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, PR China – sequence: 6 givenname: Lei surname: Chen fullname: Chen, Lei organization: The Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, PR China – sequence: 7 givenname: Wei surname: Li fullname: Li, Wei email: liwei0190@163.com organization: Department of Endocrinology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, PR China – sequence: 8 givenname: Changjiang surname: Ying fullname: Ying, Changjiang email: ycj321651@163.com organization: Department of Endocrinology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, PR China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28599877$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl9v0zAUxS20iXWDr4AinnhJdm0ndsIDYow_mzYJJMYLL5bj3LYuqdPZTqHfHkcdCE1C6pMt-5yf7HPuKTlyg0NCXlIoKFBxvipar63zGNqx7wsGVBYgCgD6hMxoLXnOZCmPyAy4oHnDOJyQ0xBWACDqSjwlJ6yumqaWckb676h_aReX1mV2vfHDFkPWWd1ixJBb140Gu8wMC2ej3WLW4dwaG7Mk9zqGLC79MC6WmTbpOkncIvtyzW_OL27usmAXTvfT0UbH5U-9e0aO57oP-PxhPSPfPn64u7zKbz9_ur68uM1NJSDmyErDOZMNVh3UEk3VmlZSqMp5RY3puKhB04q3tGy0LE1DOQNkTcVqkbYdPyOv9tz0n_sRQ1RrGwz2vXY4jEHRBuqSAxMySV88SMd2jZ3aeLvWfqf-JJQEr_cC44cQPM7_SiioqQ61Uv_WoaY6FAiV6kjmt4_MKTsd7eBisvSHId7vEZgC21r0KhiLLrViPZqousEehnnzCGNSM9bo_gfuMKyG0aeuUjQqMAXq6zQ60-RQwaEUTZUA7_4POPQVvwHAO9w2 |
CitedBy_id | crossref_primary_10_1016_j_neuint_2024_105857 crossref_primary_10_1016_j_jep_2023_116541 crossref_primary_10_1155_2023_7865919 crossref_primary_10_1186_s40168_020_00920_y crossref_primary_10_3390_ijms19082461 crossref_primary_10_1007_s00592_022_02024_5 crossref_primary_10_1111_jfpp_16571 crossref_primary_10_1016_j_biopha_2021_112610 crossref_primary_10_1016_j_tifs_2021_10_017 crossref_primary_10_1080_13813455_2022_2064878 crossref_primary_10_1007_s11011_017_0179_x crossref_primary_10_1155_2018_4120458 crossref_primary_10_1002_ptr_8122 crossref_primary_10_1016_j_biopha_2019_01_001 crossref_primary_10_3390_nu14234944 crossref_primary_10_1016_j_biopha_2018_02_089 crossref_primary_10_1080_10408398_2023_2183382 crossref_primary_10_1155_2019_7920540 crossref_primary_10_3389_fnins_2018_00694 crossref_primary_10_1007_s00394_019_02078_2 crossref_primary_10_1016_j_jff_2024_106436 crossref_primary_10_3136_fstr_24_1101 crossref_primary_10_3390_molecules25163607 crossref_primary_10_1016_j_bcab_2024_103026 crossref_primary_10_1016_j_mcp_2019_101469 crossref_primary_10_1159_000533148 crossref_primary_10_1016_j_physbeh_2017_10_001 crossref_primary_10_3390_molecules25153453 crossref_primary_10_1039_D4FO02704C crossref_primary_10_2174_2772432817666220425121323 crossref_primary_10_1016_j_fufo_2024_100517 crossref_primary_10_1111_jfbc_14382 crossref_primary_10_2174_0122103155295956240529155913 crossref_primary_10_1292_jvms_21_0268 crossref_primary_10_1016_j_toxlet_2017_11_009 crossref_primary_10_1017_S095442241900012X |
Cites_doi | 10.17116/oftalma2015131334-44 10.1001/jamaophthalmol.2015.3590 10.1016/j.neuroscience.2014.05.042 10.1111/jgs.12644 10.1258/ebm.2011.010400 10.1371/journal.pone.0095214 10.3892/mmr.2015.4232 10.3892/mmr.2015.4615 10.2337/dc12-0850 10.1007/s12020-016-0867-z 10.1038/cddis.2014.190 10.1186/s12868-016-0272-9 10.1016/j.bbrc.2015.01.098 10.3233/JAD-150199 10.1007/s11010-012-1280-4 10.1016/j.neulet.2015.09.023 10.1016/j.bbr.2015.06.024 10.1016/j.ejphar.2015.09.024 10.1016/j.diabres.2016.09.027 10.1111/nure.12133 10.1016/j.physbeh.2015.08.015 10.1016/j.neulet.2016.07.032 10.1001/jama.2015.9677 10.1016/j.bbrc.2016.03.024 10.1016/j.neuropharm.2016.10.029 10.1186/1743-7075-11-8 10.1016/j.neulet.2013.06.002 10.1007/s12017-016-8434-6 10.1016/j.bbi.2011.06.009 10.1016/j.neulet.2016.10.059 10.1093/gerona/glw078 |
ContentType | Journal Article |
Copyright | 2017 Elsevier Inc. Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.brainresbull.2017.06.001 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1873-2747 |
EndPage | 198 |
ExternalDocumentID | 28599877 10_1016_j_brainresbull_2017_06_001 S0361923016304695 1_s2_0_S0361923016304695 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 41~ 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABTEW ABWVN ABXDB ACDAQ ACGFO ACGFS ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPKN AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMQ HVGLF HZ~ IHE J1W KOM M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SNS SPCBC SSN SSZ T5K WUQ Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG 0SF AAIAV ADKLL AFMIJ AAYXX AGRNS BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c560t-e24c33279e5d087ec5bcb71054f51ccd3680a153b149a74c91320e295286132d3 |
IEDL.DBID | .~1 |
ISSN | 0361-9230 1873-2747 |
IngestDate | Fri Jul 11 16:53:58 EDT 2025 Wed Feb 19 02:41:16 EST 2025 Tue Jul 01 04:30:11 EDT 2025 Thu Apr 24 23:07:50 EDT 2025 Tue Jul 16 14:15:03 EDT 2024 Tue Feb 25 20:00:30 EST 2025 Tue Aug 26 16:34:26 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Zeaxanthin NF-κB AKT Diabetes Cognitive deficit |
Language | English |
License | Copyright © 2017 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-e24c33279e5d087ec5bcb71054f51ccd3680a153b149a74c91320e295286132d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 28599877 |
PQID | 1908430267 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1908430267 pubmed_primary_28599877 crossref_primary_10_1016_j_brainresbull_2017_06_001 crossref_citationtrail_10_1016_j_brainresbull_2017_06_001 elsevier_sciencedirect_doi_10_1016_j_brainresbull_2017_06_001 elsevier_clinicalkeyesjournals_1_s2_0_S0361923016304695 elsevier_clinicalkey_doi_10_1016_j_brainresbull_2017_06_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-06-01 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Brain research bulletin |
PublicationTitleAlternate | Brain Res Bull |
PublicationYear | 2017 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Wu, Cho, Willett, Sastry, Schaumberg (bib0120) 2015; 133 Ying, Zhou, Chang, Ling, Cheng, Li (bib0140) 2016; 53 Zhou, Zhang, Hu, Chen, Wen, Sun, Liu, Tang, Zheng, Song (bib0155) 2015; 151 Liu, Feng, Ma, Zhang, Gu, Wang, Fu, Song, Lan, Qu, Ma (bib0065) 2013; 549 Driscoll, Shumaker, Snively, Margolis, Manson, Vitolins, Rossom, Espeland (bib0020) 2016; 71 Li, Liu, Jou, Wang (bib0050) 2016; 17 Khare, Datusalia, Sharma (bib0040) 2017; 19 Zhong, Zhu, He, Li, Yan, Miao (bib0150) 2016; 610 Moshetova, Vorob’eva, Alekseev, Mikhaleva (bib0075) 2015; 131 Chin, Rhee, Chon, Baik, Park, Nam, Lee, Chun, Woo, Kim (bib0015) 2016; 122 Chew, Clemons, Agron, Launer, Grodstein, Bernstein (bib0010) 2015; 314 Bagatini, Xavier, Bertoldi, Moyses, Lovatel, Neves, Barbosa, Saur, de Senna, Souto, Siqueira, Achaval (bib0005) 2017; 636 Tang, Zhang, Jiang, Willard, Ortiz, Wark, Medeiros, Lin (bib0100) 2011; 236 Yang, Lin, Hou, Cao, Yu, Liu, Ji, Xu, Zhang, Wang (bib0130) 2014; 274 Kang, Kim, Jung, Kim, Song, Lee (bib0030) 2016; 113 Kowluru, Zhong, Santos, Thandampallayam, Putt, Gierhart (bib0045) 2014; 11 Wang, Zhao (bib0115) 2016; 473 Sen, Marsche, Freudenberger, Schallert, Toeglhofer, Nagl, Schmidt, Launer, Schmidt (bib0090) 2014; 62 Yin, Yu, Chen, Ma, Ma, Xu, Ma, Qu, Ma (bib0135) 2015; 292 Yoshino, Ishisaka, Tsujii, Shimazawa, Hara (bib0145) 2015; 458 Kelly, Coen, Akuffo, Beatty, Dennison, Moran, Stack, Howard, Mulcahy, Nolan (bib0035) 2015; 48 Theilade, Lajer, Persson, Joergensen, Rossing (bib0110) 2013; 36 Zou, Gao, Zheng, Wang, Chen, Cao, Xu, Li, Lu, Liu, Feng (bib0160) 2014; 5 Li, Qi, Zhao, Yu (bib0055) 2016; 13 Johnson (bib0025) 2014; 72 Tang, Li, Hu, Wu, Zong, Sun, Zhang, Zhang (bib0105) 2012; 365 Rahmeier, Zavalhia, Tortorelli, Huf, Gea, Meurer, Machado, Gomez, Fernandes Mda (bib0085) 2016; 630 Solmaz, Ccedil;inar, Yigitturk, Ccedil;avusoglu, Taskiran, Erbas (bib0095) 2015; 765 Lu, Wu, Zheng, Hu, Cheng, Zhang, Shan (bib0070) 2011; 25 Lindbergh, Mewborn, Hammond, Renzi-Hammond, Curran-Celentano, Miller (bib0060) 2016 Qi, Xu, Liang, Li, Wang, Wei, Dong (bib0080) 2015; 12 Xiao, Wang, Xing, Han, Jiao, Liong, Fung, So, Tipoe (bib0125) 2014; 9 Sen (10.1016/j.brainresbull.2017.06.001_bib0090) 2014; 62 Zhou (10.1016/j.brainresbull.2017.06.001_bib0155) 2015; 151 Rahmeier (10.1016/j.brainresbull.2017.06.001_bib0085) 2016; 630 Johnson (10.1016/j.brainresbull.2017.06.001_bib0025) 2014; 72 Lu (10.1016/j.brainresbull.2017.06.001_bib0070) 2011; 25 Wu (10.1016/j.brainresbull.2017.06.001_bib0120) 2015; 133 Yin (10.1016/j.brainresbull.2017.06.001_bib0135) 2015; 292 Lindbergh (10.1016/j.brainresbull.2017.06.001_bib0060) 2016 Solmaz (10.1016/j.brainresbull.2017.06.001_bib0095) 2015; 765 Theilade (10.1016/j.brainresbull.2017.06.001_bib0110) 2013; 36 Li (10.1016/j.brainresbull.2017.06.001_bib0055) 2016; 13 Kowluru (10.1016/j.brainresbull.2017.06.001_bib0045) 2014; 11 Li (10.1016/j.brainresbull.2017.06.001_bib0050) 2016; 17 Driscoll (10.1016/j.brainresbull.2017.06.001_bib0020) 2016; 71 Tang (10.1016/j.brainresbull.2017.06.001_bib0105) 2012; 365 Khare (10.1016/j.brainresbull.2017.06.001_bib0040) 2017; 19 Qi (10.1016/j.brainresbull.2017.06.001_bib0080) 2015; 12 Kang (10.1016/j.brainresbull.2017.06.001_bib0030) 2016; 113 Tang (10.1016/j.brainresbull.2017.06.001_bib0100) 2011; 236 Kelly (10.1016/j.brainresbull.2017.06.001_bib0035) 2015; 48 Liu (10.1016/j.brainresbull.2017.06.001_bib0065) 2013; 549 Moshetova (10.1016/j.brainresbull.2017.06.001_bib0075) 2015; 131 Bagatini (10.1016/j.brainresbull.2017.06.001_bib0005) 2017; 636 Yang (10.1016/j.brainresbull.2017.06.001_bib0130) 2014; 274 Chin (10.1016/j.brainresbull.2017.06.001_bib0015) 2016; 122 Zou (10.1016/j.brainresbull.2017.06.001_bib0160) 2014; 5 Zhong (10.1016/j.brainresbull.2017.06.001_bib0150) 2016; 610 Yoshino (10.1016/j.brainresbull.2017.06.001_bib0145) 2015; 458 Wang (10.1016/j.brainresbull.2017.06.001_bib0115) 2016; 473 Xiao (10.1016/j.brainresbull.2017.06.001_bib0125) 2014; 9 Ying (10.1016/j.brainresbull.2017.06.001_bib0140) 2016; 53 Chew (10.1016/j.brainresbull.2017.06.001_bib0010) 2015; 314 |
References_xml | – start-page: 1 year: 2016 end-page: 12 ident: bib0060 article-title: Relationship of lutein and zeaxanthin levels to neurocognitive functioning: an fMRI study of older adults publication-title: J. Int. Neuropsychol. Soc. – volume: 765 start-page: 482 year: 2015 end-page: 487 ident: bib0095 article-title: Exenatide reduces TNF-alpha expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats publication-title: Eur. J. Pharmacol. – volume: 473 start-page: 428 year: 2016 end-page: 434 ident: bib0115 article-title: Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway publication-title: Biochem. Biophys. Res. Commun. – volume: 636 start-page: 184 year: 2017 end-page: 189 ident: bib0005 article-title: An evaluation of aversive memory and hippocampal oxidative status in streptozotocin-induced diabetic rats treated with resveratrol publication-title: Neurosci. Lett. – volume: 610 start-page: 171 year: 2016 end-page: 176 ident: bib0150 article-title: Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels publication-title: Neurosci. Lett. – volume: 458 start-page: 274 year: 2015 end-page: 279 ident: bib0145 article-title: Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling publication-title: Biochem. Biophys. Res. Commun. – volume: 72 start-page: 605 year: 2014 end-page: 612 ident: bib0025 article-title: Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan publication-title: Nutr. Rev. – volume: 113 start-page: 467 year: 2016 end-page: 479 ident: bib0030 article-title: Agmatine ameliorates type 2 diabetes induced-Alzheimer’s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling publication-title: Neuropharmacology – volume: 236 start-page: 1051 year: 2011 end-page: 1063 ident: bib0100 article-title: Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes publication-title: Exp. Biol. Med. (Maywood) – volume: 122 start-page: 54 year: 2016 end-page: 61 ident: bib0015 article-title: Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: an analysis based on the Korea National Diabetes Program Cohort publication-title: Diabetes Res. Clin. Pract. – volume: 5 start-page: e1218 year: 2014 ident: bib0160 article-title: Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death publication-title: Cell Death Dis. – volume: 365 start-page: 363 year: 2012 end-page: 377 ident: bib0105 article-title: S-nitrosylation of c-Src via NMDAR-nNOS module promotes c-Src activation and NR2A phosphorylation in cerebral ischemia/reperfusion publication-title: Mol. Cell. Biochem. – volume: 19 start-page: 101 year: 2017 end-page: 112 ident: bib0040 article-title: Parthenolide, an NF-kappaB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model publication-title: Neuromolecular Med. – volume: 12 start-page: 7093 year: 2015 end-page: 7101 ident: bib0080 article-title: Naringin ameliorates cognitive deficits via oxidative stress, proinflammatory factors and the PPARgamma signaling pathway in a type 2 diabetic rat model publication-title: Mol. Med. Rep. – volume: 549 start-page: 63 year: 2013 end-page: 68 ident: bib0065 article-title: Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat publication-title: Neurosci. Lett. – volume: 62 start-page: 222 year: 2014 end-page: 229 ident: bib0090 article-title: Association between higher plasma lutein, zeaxanthin, and vitamin C concentrations and longer telomere length: results of the Austrian Stroke Prevention Study publication-title: J. Am. Geriatr. Soc. – volume: 53 start-page: 81 year: 2016 end-page: 96 ident: bib0140 article-title: Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats publication-title: Endocrine – volume: 314 start-page: 791 year: 2015 end-page: 801 ident: bib0010 article-title: Age-related eye disease study 2 (AREDS2) research group, effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial publication-title: JAMA – volume: 151 start-page: 412 year: 2015 end-page: 420 ident: bib0155 article-title: Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice publication-title: Physiol. Behav. – volume: 131 start-page: 34 year: 2015 end-page: 40 ident: bib0075 article-title: Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration publication-title: Vestn. Oftalmol. – volume: 133 start-page: 1415 year: 2015 end-page: 1424 ident: bib0120 article-title: Intakes of lutein, zeaxanthin, and other carotenoids and age-related macular degeneration during 2 decades of prospective follow-up publication-title: JAMA Ophthalmol. – volume: 292 start-page: 288 year: 2015 end-page: 299 ident: bib0135 article-title: Asiaticoside attenuates diabetes-induced cognition deficits by regulating PI3K/Akt/NF-kappaB pathway publication-title: Behav. Brain Res. – volume: 13 start-page: 973 year: 2016 end-page: 979 ident: bib0055 article-title: Astaxanthin reduces type 2 diabetic-associated cognitive decline in rats via activation of PI3K/Akt and attenuation of oxidative stress publication-title: Mol. Med. Rep. – volume: 25 start-page: 1658 year: 2011 end-page: 1667 ident: bib0070 article-title: Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and I kappa B kinase beta/nuclear factor-kappa B-mediated inflammatory pathways in mice publication-title: Brain Behav. Immunol. – volume: 71 start-page: 1596 year: 2016 end-page: 1602 ident: bib0020 article-title: Relationships between caffeine intake and risk for probable dementia or global cognitive impairment: the women’s health initiative memory study publication-title: J. Gerontol. A Biol. Sci. Med. Sci. – volume: 36 start-page: 715 year: 2013 end-page: 721 ident: bib0110 article-title: Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes publication-title: Diabetes Care – volume: 11 start-page: 8 year: 2014 ident: bib0045 article-title: Beneficial effects of the nutritional supplements on the development of diabetic retinopathy publication-title: Nutr. Metab. (Lond.) – volume: 274 start-page: 218 year: 2014 end-page: 228 ident: bib0130 article-title: Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: involvement of PI3K/AKT/nuclear factor-kappaB-mediated inflammatory pathways publication-title: Neuroscience – volume: 9 start-page: e95214 year: 2014 ident: bib0125 article-title: Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway publication-title: PLoS One – volume: 48 start-page: 261 year: 2015 end-page: 277 ident: bib0035 article-title: Cognitive function and its relationship with macular pigment optical density and serum concentrations of its constituent carotenoids publication-title: J. Alzheimers Dis. – volume: 630 start-page: 84 year: 2016 end-page: 92 ident: bib0085 article-title: The effect of taurine and enriched environment on behaviour, memory and hippocampus of diabetic rats publication-title: Neurosci. Lett. – volume: 17 start-page: 37 year: 2016 ident: bib0050 article-title: The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice publication-title: BMC Neurosci. – volume: 131 start-page: 34 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0075 article-title: Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration publication-title: Vestn. Oftalmol. doi: 10.17116/oftalma2015131334-44 – volume: 133 start-page: 1415 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0120 article-title: Intakes of lutein, zeaxanthin, and other carotenoids and age-related macular degeneration during 2 decades of prospective follow-up publication-title: JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2015.3590 – volume: 274 start-page: 218 year: 2014 ident: 10.1016/j.brainresbull.2017.06.001_bib0130 article-title: Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: involvement of PI3K/AKT/nuclear factor-kappaB-mediated inflammatory pathways publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.05.042 – volume: 62 start-page: 222 year: 2014 ident: 10.1016/j.brainresbull.2017.06.001_bib0090 article-title: Association between higher plasma lutein, zeaxanthin, and vitamin C concentrations and longer telomere length: results of the Austrian Stroke Prevention Study publication-title: J. Am. Geriatr. Soc. doi: 10.1111/jgs.12644 – volume: 236 start-page: 1051 year: 2011 ident: 10.1016/j.brainresbull.2017.06.001_bib0100 article-title: Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes publication-title: Exp. Biol. Med. (Maywood) doi: 10.1258/ebm.2011.010400 – volume: 9 start-page: e95214 year: 2014 ident: 10.1016/j.brainresbull.2017.06.001_bib0125 article-title: Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway publication-title: PLoS One doi: 10.1371/journal.pone.0095214 – volume: 12 start-page: 7093 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0080 article-title: Naringin ameliorates cognitive deficits via oxidative stress, proinflammatory factors and the PPARgamma signaling pathway in a type 2 diabetic rat model publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.4232 – volume: 13 start-page: 973 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0055 article-title: Astaxanthin reduces type 2 diabetic-associated cognitive decline in rats via activation of PI3K/Akt and attenuation of oxidative stress publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.4615 – volume: 36 start-page: 715 year: 2013 ident: 10.1016/j.brainresbull.2017.06.001_bib0110 article-title: Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes publication-title: Diabetes Care doi: 10.2337/dc12-0850 – volume: 53 start-page: 81 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0140 article-title: Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats publication-title: Endocrine doi: 10.1007/s12020-016-0867-z – volume: 5 start-page: e1218 year: 2014 ident: 10.1016/j.brainresbull.2017.06.001_bib0160 article-title: Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death publication-title: Cell Death Dis. doi: 10.1038/cddis.2014.190 – volume: 17 start-page: 37 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0050 article-title: The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice publication-title: BMC Neurosci. doi: 10.1186/s12868-016-0272-9 – volume: 458 start-page: 274 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0145 article-title: Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.01.098 – volume: 48 start-page: 261 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0035 article-title: Cognitive function and its relationship with macular pigment optical density and serum concentrations of its constituent carotenoids publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-150199 – volume: 365 start-page: 363 year: 2012 ident: 10.1016/j.brainresbull.2017.06.001_bib0105 article-title: S-nitrosylation of c-Src via NMDAR-nNOS module promotes c-Src activation and NR2A phosphorylation in cerebral ischemia/reperfusion publication-title: Mol. Cell. Biochem. doi: 10.1007/s11010-012-1280-4 – volume: 610 start-page: 171 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0150 article-title: Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2015.09.023 – volume: 292 start-page: 288 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0135 article-title: Asiaticoside attenuates diabetes-induced cognition deficits by regulating PI3K/Akt/NF-kappaB pathway publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2015.06.024 – volume: 765 start-page: 482 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0095 article-title: Exenatide reduces TNF-alpha expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2015.09.024 – volume: 122 start-page: 54 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0015 article-title: Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: an analysis based on the Korea National Diabetes Program Cohort publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2016.09.027 – volume: 72 start-page: 605 year: 2014 ident: 10.1016/j.brainresbull.2017.06.001_bib0025 article-title: Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan publication-title: Nutr. Rev. doi: 10.1111/nure.12133 – volume: 151 start-page: 412 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0155 article-title: Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2015.08.015 – volume: 630 start-page: 84 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0085 article-title: The effect of taurine and enriched environment on behaviour, memory and hippocampus of diabetic rats publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2016.07.032 – start-page: 1 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0060 article-title: Relationship of lutein and zeaxanthin levels to neurocognitive functioning: an fMRI study of older adults publication-title: J. Int. Neuropsychol. Soc. – volume: 314 start-page: 791 year: 2015 ident: 10.1016/j.brainresbull.2017.06.001_bib0010 article-title: Age-related eye disease study 2 (AREDS2) research group, effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2015.9677 – volume: 473 start-page: 428 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0115 article-title: Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.03.024 – volume: 113 start-page: 467 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0030 article-title: Agmatine ameliorates type 2 diabetes induced-Alzheimer’s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2016.10.029 – volume: 11 start-page: 8 year: 2014 ident: 10.1016/j.brainresbull.2017.06.001_bib0045 article-title: Beneficial effects of the nutritional supplements on the development of diabetic retinopathy publication-title: Nutr. Metab. (Lond.) doi: 10.1186/1743-7075-11-8 – volume: 549 start-page: 63 year: 2013 ident: 10.1016/j.brainresbull.2017.06.001_bib0065 article-title: Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2013.06.002 – volume: 19 start-page: 101 issue: March (1) year: 2017 ident: 10.1016/j.brainresbull.2017.06.001_bib0040 article-title: Parthenolide, an NF-kappaB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model publication-title: Neuromolecular Med. doi: 10.1007/s12017-016-8434-6 – volume: 25 start-page: 1658 year: 2011 ident: 10.1016/j.brainresbull.2017.06.001_bib0070 article-title: Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and I kappa B kinase beta/nuclear factor-kappa B-mediated inflammatory pathways in mice publication-title: Brain Behav. Immunol. doi: 10.1016/j.bbi.2011.06.009 – volume: 636 start-page: 184 year: 2017 ident: 10.1016/j.brainresbull.2017.06.001_bib0005 article-title: An evaluation of aversive memory and hippocampal oxidative status in streptozotocin-induced diabetic rats treated with resveratrol publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2016.10.059 – volume: 71 start-page: 1596 year: 2016 ident: 10.1016/j.brainresbull.2017.06.001_bib0020 article-title: Relationships between caffeine intake and risk for probable dementia or global cognitive impairment: the women’s health initiative memory study publication-title: J. Gerontol. A Biol. Sci. Med. Sci. doi: 10.1093/gerona/glw078 |
SSID | ssj0006856 |
Score | 2.382209 |
Snippet | •Diabetes- induced cognitive deficit could be ameliorated by zeaxanthin.•Zeaxanthin could protect hippocampal neurons against hyperglycemia.•Zeaxanthin... Highlights • Diabetes- induced cognitive deficit could be ameliorated by zeaxanthin. • Zeaxanthin could protect hippocampal neurons against hyperglycemia. •... Published studies have shown that cognitive deficit is a characteristic manifestation of neurodegenerative disease in diabetes. However, there is no effective... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 190 |
SubjectTerms | Active Transport, Cell Nucleus - drug effects Active Transport, Cell Nucleus - physiology AKT Animals Caspase 3 - metabolism Cell Survival - drug effects Cell Survival - physiology Cognition Disorders - drug therapy Cognition Disorders - enzymology Cognition Disorders - etiology Cognition Disorders - pathology Cognitive deficit Diabetes Diabetes Mellitus, Experimental - drug therapy Diabetes Mellitus, Experimental - enzymology Diabetes Mellitus, Experimental - pathology Diabetes Mellitus, Experimental - psychology Hippocampus - drug effects Hippocampus - enzymology Hippocampus - pathology Hypoglycemic Agents - chemistry Hypoglycemic Agents - pharmacology Male Maze Learning - drug effects Maze Learning - physiology Neurology Neurons - drug effects Neurons - enzymology Neurons - pathology Neuroprotective Agents - chemistry Neuroprotective Agents - pharmacology NF-kappa B - metabolism NF-κB Nootropic Agents - chemistry Nootropic Agents - pharmacology Phosphatidylinositol 3-Kinases - metabolism Proto-Oncogene Proteins c-akt - metabolism Rats, Sprague-Dawley Signal Transduction - drug effects Zeaxanthin Zeaxanthins - chemistry Zeaxanthins - pharmacology |
Title | Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0361923016304695 https://www.clinicalkey.es/playcontent/1-s2.0-S0361923016304695 https://dx.doi.org/10.1016/j.brainresbull.2017.06.001 https://www.ncbi.nlm.nih.gov/pubmed/28599877 https://www.proquest.com/docview/1908430267 |
Volume | 132 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3daxQxEB9KfemLqK16fpQIpW_p7eXjsov4cBTLtYVS0ELxJSTZLK7UbXGval_8253ZzZ4VLRz0cZcdsiSTyW8yv5kB2KkqVznpDC_FRHLUkJy7oDMeQmGikj4LoWNbnEznZ-roXJ-vwf6QC0O0ymT7e5veWev0Zpxmc3xV1-MPaHsJniBmoeheQYnmShnS8r1ff2ge01yneOWE09dD4dGO4-WpDQO6tR7dPaJ5mb0-NnHXIXUXCO0Oo4NH8DChSDbrf_QxrMXmCWzOGvSgv96wXdbxOrsL8024-BTdT5y_z3XD6u4KIbZsuHLl6JLj4pZsSSNiZaSiEguGn6N2tCx18mGUAfG9JpY0Oz2Ux2NEh4zYH44S2hl1Nv7hbrbg7OD9x_05Tz0WeECss-BRqCClMEXUZZabGLQPHlGHVpWehFDKaZ45tIoePSlnVCgo5TqKQoscgYAo5VNYby6b-ByYNN7pvJS6RJ_OaeEraQyewZlUrhJOjaAYJtWGVICc-mBc2IFp9sXeXhBLC2J72t0I5FL2qi_DsZLU22Ht7JBoiqbR4mmxkrT5n3Rs0y5v7cS2wmb2H00cwbul5F_KvPLIbwZFs7jbKYTjmnh5jSMWWa4kdQ0bwbNeA5fzQaUIi9yYF_cc_SVs0FPPh3sF64tv1_E1Iq-F3-621jY8mB0ez09-A9q5MOw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-N8QAvCBiwjgFGAt68pnZcJ0J7mICppWNCYpMmXozjOCJoZNPSbfRlX2pfkLvEKSCYVAnttenF0d35_ti_uwN4URS2sNJqnouB5KghCbdORdy5VPtYZpFzDdpidzjaj98fqIMluOxqYQhWGWx_a9Mbax1-6Qdu9o_Lsv8JbS-FJxiz0O1e2iErJ352jnlbvTl-i0J-KcT2u703Ix5GC3CHLn7KvYidlEKnXuVRor1TmcvQ2aq4UAPncjlMIovGIMMEwurYpVRp7EWqRIL-T-QS33sDbsZoLmhswsbFL1zJMFHhgnTA6fO6TqcNqCyjuQ-YR2eYXxKuTG-0lyFXecWrot7G-23fhTshbGVbLWfuwZKv7sPKVoUp-_cZe8UaIGlzQr8Ch5-9_YEC-1pWrGzOLHzNujNeXlY5alPO5rgllnvqYjFl-HdUx5qF0UGMSi7OSoJls49jOeljOMoIbmKpgp7RKOVzO3sA-9fC-YewXB1VfhWY1JlVSS5VjkmkVSIrpNbo9CMZ20LYuAdpx1TjQsdzGrxxaDpo2zfzu0AMCcS0OL8eyDntcdv3YyGq153sTFfZirbYoHtaiFr_i9rXwazUZmBqYSLzl-r3YHNO-cfuWXjl552iGTQvdGdkK390iiumURJLGlPWg0etBs75Qb0P00Trtf9c_RncGu192DE7493JY7hNT1ow3josT09O_RMM-6bZ02abMfhy3fv6J2j-alI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Zeaxanthin+improves+diabetes-induced+cognitive+deficit+in+rats+through+activiting+PI3K%2FAKT+signaling+pathway&rft.jtitle=Brain+research+bulletin&rft.au=Zhou%2C+Xiaoyan&rft.au=Wang%2C+Shanshan&rft.au=Ding%2C+Xin&rft.au=Qin%2C+Li&rft.date=2017-06-01&rft.issn=1873-2747&rft.eissn=1873-2747&rft.volume=132&rft.spage=190&rft_id=info:doi/10.1016%2Fj.brainresbull.2017.06.001&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03619230%2Fcov200h.gif |